Admatop 2.5 Injection

Topotecan (1.0mg/ml)

Genuine

Authenticity Assured

Prescription

required

Cold stored

Stored between 2-8°C

Admatop 2.5 Injection is used in the treatment of ovarian cancer. It shows its working by stopping or slowing down the growth of cancer cells.

Written By Dr. Subita Alagh, BDS,
Reviewed By Dr. Rajeev Sharma, MBA, MBBS,
Last updated on 25 Nov 2025 | 03:05 PM (IST)

₹4271 MRP ₹496714% off

Gurgaon

Save more with additional offers

Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15

Earn cashback up to Rs.75 with Amazon Pay Later

Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.

Pay with Amazon Pay Balance and get cashback up to Rs. 75 with minimum cashback of Rs. 15

Earn cashback up to Rs.75 with Amazon Pay Later

Get upto Rs.500 Cashback on minimum transaction of Rs.999/- with Mobikwik Wallet.

Get upto Rs.150 Cashback on minimum transaction of Rs.599/- with Mobikwik UPI.

Flat Rs.150 on a Min Transaction of Rs.1000.

Assured cashback up to ₹300 on minimum payment of ₹300 using Paytm UPI*

General Information

Contains

Topotecan (1.0mg/ml)

Marketer

Admac Pharma Ltd

Storage

Store in a refrigerator (2 - 8°C). Do not freeze.

The content is shown in English

Product introduction

Admatop 2.5 Injection is given as an IV infusion into vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include tiredness, vomiting, weakness, nausea, and abdominal pain. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Inform your doctor if you notice fever, chills, sore throat, and severe diarrhea. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses of Admatop Injection

Ovarian cancer

Benefits of Admatop Injection

Ovarian cancer
Ovarian cancer is a cancer that begins in the female organs that produce eggs (ovaries). This type of cancer is usually detected very late and can be fatal too. It usually spreads to the pelvis and stomach. Admatop 2.5 Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective medicine but has some side effects that may be bothersome. Consult your doctor to know about ways that can help you avoid these side effects.

Side effects of Admatop Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Admatop

Tiredness
Vomiting
Weakness
Nausea
Abdominal pain
Indigestion
Decreased white blood cell count
Decreased blood cells (red cells, white cells, and platelets)
Diarrhea
Injection site reactions (pain, swelling, redness)

How to use Admatop Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

How Admatop Injection works

Admatop 2.5 Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase I) involved in DNA multiplication of the cancer cells. This slows the growth of cancer cells and eventually kills them.

Quick tips

Admatop 2.5 Injection helps treat ovarian cancer.
It is given by a drip into a vein (intravenous infusion).
Do not drive or operate machinery as Admatop 2.5 Injection may cause tiredness, drowsiness or weakness.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
Your doctor may get regular blood tests done to monitor your blood cells during treatment with this medicine.
Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea.

Safety advice

Alcohol

SAFE

Consuming alcohol with Admatop 2.5 Injection does not usually cause any harmful side effects.

Pregnancy

CONSULT YOUR DOCTOR

Admatop 2.5 Injection is not recommended during pregnancy as there is positive evidence of fetal risk based on animal studies. However, it may still be prescribed by a doctor in situations where the benefits outweigh the risks.

Breast feeding

UNSAFE

Admatop 2.5 Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.

Driving

UNSAFE

Admatop 2.5 Injection may cause side effects that could affect your ability to drive.
Admatop 2.5 Injection can make you feel tired and this may affect your ability to drive.

Kidney

CAUTION

Admatop 2.5 Injection should be used with caution in patients with kidney disease. Dose adjustment may be needed.
Use of Admatop 2.5 Injection is not recommended in patients with end-stage kidney disease.

Liver

SAFE IF PRESCRIBED

Admatop 2.5 Injection is safe to use in patients with liver disease. No dose adjustment is recommended.

Interaction with drugs

Taking Admatop with any of the following medicines can modify the effect of either of them and cause some undesirable side effects

Severe

Filgrastim (Injection Route)

Avoid Filgrastim within 24 hours before and 24 hours after the last dose of Topotecan.

Severe

Pegfilgrastim (Injection Route)

Avoid Pegfilgrastim within 24 hours before and 24 hours after the last dose of Topotecan.

Severe

Sargramostim (Injection Route)

Avoid Sargramostim within 24 hours before and 24 hours after the last dose of Topotecan.

Severe

Lenograstim (Injection Route)

Avoid Lenograstim within 24 hours before and 24 hours after the last dose of Topotecan.

Severe

Molgramostim (Injection Route)

Avoid Molgramostim within 24 hours before and 24 hours after the last dose of Topotecan.

Frequently asked questions

How often is Admatop 2.5 Injection given?

Generally Admatop 2.5 Injection treatment is for 4 cycles of 21 day each, patient is given Admatop 2.5 Injection for first 5 days of each cycle.

Does Admatop 2.5 Injection cause hair loss?

Yes, Admatop 2.5 Injection may cause temporary hair loss.

Does Admatop 2.5 Injection cause flare reaction?

Yes, Admatop 2.5 Injection may cause flare reaction.

How long does Admatop 2.5 Injection take to work?

Admatop 2.5 Injection may start its action once the infusion is started, however, the complete effect may be assessed only after completion of 4 cycles.

Is Admatop 2.5 Injection a vesicant?

Admatop 2.5 Injection is a vesicant (irritant).

Is Admatop 2.5 Injection effective?

Yes Admatop 2.5 Injection is effective if used at prescribed doses for the prescribed duration as advised by your doctor.

What is Admatop 2.5 Injection chemotherapy?

It is a treatment therapy that includes Admatop 2.5 Injection with or without combination of other drugs in treatment of cancer (Usually ovarian or lung cancer).

How is Admatop 2.5 Injection administered?

Admatop 2.5 Injection is either administered orally as a capsule or as an intravenous Infusion in the arm over a period of 30 min.

Fact Box

Chemical Class

Camptothecins

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Topoisomerase Inhibitors

References

Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1711-12.
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 951.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1383.
Topotecan hydrochloride. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 1996 [revised 23 Apr. 2018]. [Accessed 24 Jan. 2019] (online) Available from:
Topotecan. Unterach, Austria: Ebewe Pharma; 1996 [revised Feb. 2014]. [Accessed 27 Mar. 2019] (online) Available from:
Central Drugs Standard Control Organisation (CDSCO). [Accessed 27 Mar. 2019] (online) Available from:
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Topotecan. [Updated 2018 Dec 3]. [Accessed 19 Feb. 2020] (online) Available from:

Want to know more

We provide you with authentic, trustworthy and relevant information

Have issue with the content

Disclaimer

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

Marketer details

Name: Admac Pharma Ltd
Address: SCO 84, Sector 5, Panchkula (Haryana), 134112 INDIA.

Vendor Details

Country of origin: India

Lab tests offered by us

Why we need a prescription?

Admatop 2.5 Injection

Save more with additional offers

General Information

Contains

Marketer

Storage

Product introduction

Uses of Admatop Injection

Benefits of Admatop Injection

Side effects of Admatop Injection

How to use Admatop Injection

How Admatop Injection works

Quick tips

Safety advice

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver

Interaction with drugs

Filgrastim (Injection Route)

Pegfilgrastim (Injection Route)

Sargramostim (Injection Route)

Lenograstim (Injection Route)

Molgramostim (Injection Route)

Frequently asked questions

How often is Admatop 2.5 Injection given?

Does Admatop 2.5 Injection cause hair loss?

Does Admatop 2.5 Injection cause flare reaction?

How long does Admatop 2.5 Injection take to work?

Is Admatop 2.5 Injection a vesicant?

Is Admatop 2.5 Injection effective?

What is Admatop 2.5 Injection chemotherapy?

How is Admatop 2.5 Injection administered?

Fact Box

Chemical Class

Habit Forming

Therapeutic Class

Action Class

References

Want to know more

Have issue with the content

Disclaimer

Marketer details

Vendor Details

Lab tests offered by us

Related/Popular tests